Table 1 Demographic and clinical characteristics, N = 18
Variable | Participants n (%) |
|---|---|
Gender | |
Male | 14 (77.8) |
Ethnicity | |
White | 7 (38.9) |
Hispanic | 2 (11.1) |
African American | 7 (38.9) |
Other | 2 (11.1) |
Number of Medications | M (SD) 6.8 |
Comorbidities | n (%) |
Hypertension | 14 (77.8) |
Hyperlipidemia | 7 (38.9) |
Diabetes Mellitus | 3 (16.7) |
Congestive Heart Failure | 6 (33.3) |
Depression | 4 (22.2) |
Coronary Artery Disease | 5 (27.8) |
Chronic Obstructive Pulmonary | 5 (27.8) |
Disease | |
n (%)a | |
Indication for Warfarin Therapy | 5 (27.8) |
Atrial fibrillation | 4 (22.2) |
Pulmonary embolism | 4 (22.2) |
Deep vein thrombosis | 3 (16.7) |
Heart valve | 2 (11.1) |
Mural thrombus | |